Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research

    NEXT STORY
    Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States
    PREV STORY
    American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aquinox Pharmaceuticals Announces Year End 2016 Financial Results

    VANCOUVER, British Columbia, March 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION

    author_avatar
    NASDAQ Market News

    Medicaid Expansion Could Harm Rural Healthcare, States Association of American Physicians and Surgeons (AAPS)

    TUCSON, Ariz., Sept. 28, 2018 (GLOBE NEWSWIRE) -- Medicaid expansion is on the November ...

    author_avatar
    NASDAQ Market News